Personal profile
Headline
Biography
Fingerprint
- 1 Similar Profiles
-
A perspective on hpk1 as a novel immuno-oncology drug target
Sawasdikosol, S. & Burakoff, S., Sep 2020, In: eLife. 9, p. 1-15 15 p., e55122.Research output: Contribution to journal › Review article › peer-review
Open Access60 Scopus citations -
HPK1 Influences Regulatory T Cell Functions
Sawasdikosol, S., Zha, R., Fisher, T. S., Alzabin, S. & Burakoff, S. J., 1 Jul 2020, In: ImmunoHorizons. 4, 7, p. 382-391 10 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations -
Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation
Johnson, E., McTigue, M., Gallego, R. A., Johnson, T. W., Timofeevski, S., Maestre, M., Fisher, T. S., Kania, R., Sawasdikosol, S., Burakoff, S. & Cronin, C. N., 7 Jun 2019, In: Journal of Biological Chemistry. 294, 23, p. 9029-9036 8 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
The Structure of HPK1 Kinase Domain: To Boldly Go Where No Immuno-Oncology Drugs Have Gone Before
Sawasdikosol, S. & Burakoff, S., 2 Jan 2019, In: Structure. 27, 1, p. 1-3 3 p.Research output: Contribution to journal › Short survey › peer-review
Open Access9 Scopus citations -
The role of accessory molecules in T cell recognitions
Greenstein, J. L., Mentzer, S. J. & Burakoff, S. J., 1 Jan 2018, Cytolytic Lymphocytes and Complement Effectors of the Immune System. CRC Press, Vol. 1. p. 127-142 16 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
Press/Media
-
U.S. Patents Awarded to Inventors in New York (Nov. 12)
Kaniskan, Ü., Jin, J., Brody, J., Burakoff, S. & Bhardwaj, N.
12/11/25
1 item of Media coverage
Press/Media
-
Heterobifunctional Compounds as Degraders of HPK1
Kaniskan, Ü., Jin, J., Brody, J., Burakoff, S. & Bhardwaj, N.
11/11/25
1 item of Media coverage
Press/Media
-
Mount Sinai's Nina Bhardwaj Elected to National Academy of Medicine for Contributions to Cancer Immunotherapy
Merad, M., Davis, K. L., Nestler, E. J., Richardson, L. D., Yehuda, R., Sampson, H., Diaz, A., Palese, P., Calman, N., Charney, D., Siu, A., Mayberg,, H., Buxbaum, J., Bhardwaj, N., Gelb, B., Meier, D., Hurd, Y., Desnick, R., Goate, A., Burakoff, S., Vickrey, B. G., Garcia-Sastre, A. & Parsons, R.
6/11/24
1 item of Media coverage
Press/Media
-
Mount Sinai’s Nina Bhardwaj Elected to National Academy of Medicine for Contributions to Cancer Immunotherapy
Merad, M., Davis, K. L., Nestler, E. J., Richardson, L. D., Yehuda, R., Sampson, H., Diaz, A., Palese, P., Calman, N., Garcia-Sastre, A., Charney, D., Siu, A., Mayberg,, H., Buxbaum, J., Bhardwaj, N., Gelb, B., Meier, D., Hurd, Y., Desnick, R., Goate, A., Burakoff, S., Vickrey, B. G. & Parsons, R.
6/11/24
1 item of Media coverage
Press/Media
-
Australia Patent: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, CULLINAN ONCOLOGY File Application for 'HETEROBIFUNCTIONAL COMPOUNDS AS HPK1 DEGRADERS'
Jin, J., Burakoff, S. & Kaniskan, Ü.
14/06/24
1 item of Media coverage
Press/Media